| Product Code: ETC13143828 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Legalized Cannabis Medical Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Legalized Cannabis Medical Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Legalized Cannabis Medical Market Revenues & Volume, 2021 & 2031F |
3.3 North America Legalized Cannabis Medical Market - Industry Life Cycle |
3.4 North America Legalized Cannabis Medical Market - Porter's Five Forces |
3.5 North America Legalized Cannabis Medical Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Legalized Cannabis Medical Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 North America Legalized Cannabis Medical Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.8 North America Legalized Cannabis Medical Market Revenues & Volume Share, By End Use, 2021 & 2031F |
3.9 North America Legalized Cannabis Medical Market Revenues & Volume Share, By Compound, 2021 & 2031F |
4 North America Legalized Cannabis Medical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Legalized Cannabis Medical Market Trends |
6 North America Legalized Cannabis Medical Market, 2021 - 2031 |
6.1 North America Legalized Cannabis Medical Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Legalized Cannabis Medical Market, Revenues & Volume, By Cannabis Herb, 2021 - 2031 |
6.1.3 North America Legalized Cannabis Medical Market, Revenues & Volume, By Cannabis Resin, 2021 - 2031 |
6.2 North America Legalized Cannabis Medical Market, Revenues & Volume, By Form, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Legalized Cannabis Medical Market, Revenues & Volume, By Raw, 2021 - 2031 |
6.2.3 North America Legalized Cannabis Medical Market, Revenues & Volume, By Processed, 2021 - 2031 |
6.3 North America Legalized Cannabis Medical Market, Revenues & Volume, By End Use, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Legalized Cannabis Medical Market, Revenues & Volume, By Recreational, 2021 - 2031 |
6.3.3 North America Legalized Cannabis Medical Market, Revenues & Volume, By Medicinal, 2021 - 2031 |
6.4 North America Legalized Cannabis Medical Market, Revenues & Volume, By Compound, 2021 - 2031 |
6.4.2 North America Legalized Cannabis Medical Market, Revenues & Volume, By THC-Dominant, 2021 - 2031 |
6.4.3 North America Legalized Cannabis Medical Market, Revenues & Volume, By CBD-Dominant, 2021 - 2031 |
6.4.4 North America Legalized Cannabis Medical Market, Revenues & Volume, By Balanced THC & CBD, 2021 - 2031 |
7 North America Legalized Cannabis Medical Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Legalized Cannabis Medical Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.1 United States (US) Legalized Cannabis Medical Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.2 Canada Legalized Cannabis Medical Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.3 Rest of North America Legalized Cannabis Medical Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3 North America Legalized Cannabis Medical Market Revenues & Volume Share, By Form, 2021 & 2031F |
7.3.1 United States (US) Legalized Cannabis Medical Market, Revenues & Volume, By Form, 2021 - 2031 |
7.3.2 Canada Legalized Cannabis Medical Market, Revenues & Volume, By Form, 2021 - 2031 |
7.3.3 Rest of North America Legalized Cannabis Medical Market, Revenues & Volume, By Form, 2021 - 2031 |
7.4 North America Legalized Cannabis Medical Market, Revenues & Volume, By End Use, 2021 - 2031 |
7.4.1 United States (US) Legalized Cannabis Medical Market, Revenues & Volume, By End Use, 2021 - 2031 |
7.4.2 Canada Legalized Cannabis Medical Market, Revenues & Volume, By End Use, 2021 - 2031 |
7.4.3 Rest of North America Legalized Cannabis Medical Market, Revenues & Volume, By End Use, 2021 - 2031 |
7.5 North America Legalized Cannabis Medical Market, Revenues & Volume, By Compound, 2021 - 2031 |
7.5.1 United States (US) Legalized Cannabis Medical Market, Revenues & Volume, By Compound, 2021 - 2031 |
7.5.2 Canada Legalized Cannabis Medical Market, Revenues & Volume, By Compound, 2021 - 2031 |
7.5.3 Rest of North America Legalized Cannabis Medical Market, Revenues & Volume, By Compound, 2021 - 2031 |
8 North America Legalized Cannabis Medical Market Key Performance Indicators |
9 North America Legalized Cannabis Medical Market - Export/Import By Countries Assessment |
10 North America Legalized Cannabis Medical Market - Opportunity Assessment |
10.1 North America Legalized Cannabis Medical Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Legalized Cannabis Medical Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10.3 North America Legalized Cannabis Medical Market Opportunity Assessment, By Form, 2021 & 2031F |
10.4 North America Legalized Cannabis Medical Market Opportunity Assessment, By End Use, 2021 & 2031F |
10.5 North America Legalized Cannabis Medical Market Opportunity Assessment, By Compound, 2021 & 2031F |
11 North America Legalized Cannabis Medical Market - Competitive Landscape |
11.1 North America Legalized Cannabis Medical Market Revenue Share, By Companies, 2022 |
11.2 North America Legalized Cannabis Medical Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here